SuperGen to Present Data at the 50th ASH Annual Meeting & Exposition
DUBLIN, Calif., December 02, 2008 /PRNewswire-FirstCall/ -- SuperGen, Inc. , a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced the company's plans to present three posters at the 50th American Society of Hematology (ASH) Annual Meeting & Exposition on December 7 and 8, 2008.
SuperGen's presentations will review clinical and non-clinical advances in the following compounds: SGI-1776, SGI-1252, and SGI-110. All presentations will occur as poster presentations.
Abstract Number/Title Date
Abstract 1922: Inhibiting PIM-1 is Effective in Vitro
and in Vivo against ALL: A Novel Mechanistic and
Potentially Clinically Relevant Druggable Target Dec 7
Abstract 2629: Preclinical Characterization of the
JAK-2 Inhibitor, SGI-1252 Dec 7
Abstract 3355: Anti-AML Activity of Combined Epigenetic
Therapy with Novel DNMT1 Inhibitors SGI-110 or SGI-1036
and Histone Deacetylase Inhibitor Panobinostat Dec 8
About SuperGen
Based in Dublin, Calif., SuperGen, Inc. is a pharmaceutical company dedicated to the discovery and development of novel cancer therapies. SuperGen is developing a number of therapeutic anticancer products focused on kinase and cell signaling inhibitors and DNA methyltransferase inhibitors. For more information about SuperGen, please visit http://www.supergen.com.
Contacts:
SuperGen, Inc. Dorland Global Public Relations
Timothy L. Enns Michael Beckerich (Media)
SVP, Corporate Communications Tel: (212) 677-7632
& Business Development mbeckerich@dorland.com
Tel: (925) 560-2810
Email: tenns@supergen.com
CONTACT: Timothy L. Enns, SVP, Corporate Communications & BusinessDevelopment of SuperGen, Inc., +1-925-560-2810, ; orMedia, Michael Beckerich for SuperGen, Inc., +1-212-677-7632, tenns@supergen.com mbeckerich@dorland.com
Web site: http://www.supergen.com/
Ticker Symbol: (NASDAQ-NMS:SUPG)
Terms and conditions of use apply
Copyright © 2008 PR Newswire Association LLC. All rights reserved.
A United Business Media Company
